Join your peers and leading players in the worldwide biopharmaceutical industry to develop and foster collaboration among local and international companies and institutions.

Companies in China are increasingly being perceived as competitors and potential partners in novel biotherapeutics development. Local conglomerates are setting up biotherapeutic arms; multi-nationals are localizing research and development; innovative returnees are starting up new biotech ventures; and universities are spinning off novel ideas and training future generations in the protein sciences. All these are making China a fertile ground for the growth of novel biotherapeutics.

In its third year, PEGS China: Protein and Antibody Engineering & Development Summit returns to Shanghai for 3 days of inspiring presentations and case studies featuring the latest trends and future potential of China’s biotech industry.

This year’s event comprises four content-driven conferences with over sixty global speakers, plus a new seminar on clinical & regulatory strategies for global and domestic IND and BLA filings. In addition, dedicated exhibit hall and poster viewing hours will provide invaluable opportunities for networking, deal-making and ideas exchange.

April 5-6, 2016

 

Protein and Antibody Engineering

 




Analytical Characterization

 




April 6-7, 2016

 

Next Geneartion

 




Protein Aggregation & Stability

 




ClinicalAndRegulatoryStrategies_Logo

 






 

Keynote Speakers

 

Alain BeckAlain Beck, Ph.D., Senior Director, Antibody and ADC Physico-Chemistry, Centre d’Immunologie Pierre Fabre


Parren PaulPaul W.H.I. Parren, Ph.D., Senior Vice President & Scientific Director, Genmab


Ventura SalvadorSalvador Ventura, Ph.D., Professor, Biochemistry and Molecular Biology, Institute of Biotechnology and Biomedicine, University of Barcelona


Bradbury AndrewAndrew Bradbury, MBBS, Ph.D., Biosciences Division, Los Alamos National Laboratory


Weikang TaoWeikang Tao, Ph.D., Vice President & CEO, R&D Center, Jiangsu Henrui Medicine Co., Ltd.


Wu HerrenHerren Wu, Ph.D., Chief Technology Officer, MedImmune/AstraZeneca


Roland KontermannRoland Kontermann, Ph.D., Professor, Biomedical Engineering, Institute of Cell Biology and Immunology, University of Stuttgart


Tessier PeterPeter M. Tessier, Ph.D., Richard Baruch M.D. Career Development, Associate Professor, Chemical & Biological Engineering, Rensselaer Polytechnic Institute


 



Hear from past attendees on their PEGS China experience:

“This conference is very successful, in my opinion, for it not only invites the top scientists in the field of therapeutic antibody, but also this event gives a chance for local companies to present their scientific achievements. I enjoyed the talks very much. Thank you again for the organization.”
- Liang (Leo) Qu, Ph.D., Roche Pharmaceutical Research and Early Development

“Congratulations on a successful PEGS China meeting. As a speaker and chair, I really enjoyed the conference and interactions with the attendees.”
- Kedan Lin, Genentech, Inc.

“Thanks again for such a great PEGS China in Shanghai - I really enjoyed meeting you again and attending this again very well organized conference! A job well done!”
- Jonas Schaefer, Ph.D., University of Zurich

“Thanks again for a great conference, I really enjoyed my PEGS-China experience.”
- Jonathan Lai, Ph.D., Albert Einstein College of Medicine

“I really enjoyed the conference and made some great contacts.”
- Stephen Mahler, Ph.D., University of Queensland

“I had a wonderful time and thought the conference was a success!”
- Thomas Pillow, Ph.D., Genentech, Inc.


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


Register Early

 

Download 2016 Brochure
2016 ABA Brochure Icon

 

Premier Sponsor
Protein Simple

Thermo Scientific logo

Unchained Labs

View All Sponsors >

View Media Partners >

Promote your company’s latest technology and/or solution at PEGS CHINA. A limited number of agenda presentations (as part of a sponsorship package), exhibit space, branding, and promotional opportunities are available.


Track 1

Protein & Antibody Engineering

Track 2

Analytical Characterization of Biotherapeutics

Track 3

Next-Generation Cancer Biotherapeutics

Track 4

Protein Aggregation & Stability

Seminar

Clinical and Regulatory Strategies for Domestic and Global IND And BLA Filings